FINANCIALS

BIOL Biolase Inc 811240

Income Statement
Revenue	biol-20240930	10,850,000
Net Income	biol-20240930	-1,428,000
Profit Margin		-13.16%

Balance Sheet
Current Assets	19,428,000
Assets	27,241,000
Current Liabilities	30,859,000
Liabilities	32,468,000
Equity	-5,227,000
Shares Out	33,395,000

Cash Flow Statement
Operating Cash Flow	-11,144,000
Investing Cash Flow	291,000

Market Analysis
Market Cap	2,160,949
BVPS	0.78
PB	0.20
EPS	-20.50
PS	0.05
FCF	-10,853,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view BIOL documents filed with the SEC.

BIOL Filings Clear

View A List of Tickers